Est-ce que quelqu’un l’a ridé ? Je l’ai vu rapidement sur mon radar Vendredi quand il avait déjà pris 100% autour de 3$, je n’ai pas pris la peine de regarder me disant une autre pharma qui se fait acheter. Il a fini la journée au dessus de 10$ et maintenant en pre-market il a déjà plus de 1M de volume et se transige autour de 18$. Assez fou comme ride.
Shares of Canadian drug company Aquinox Pharmaceuticals Inc. AQXP, +74.18% skyrocketed more than 450% Friday after the company released positive mid-stage trial results for an inflammation therapy targeted toward patients with bladder pain syndrome, or interstitial cystitis. Its shares traded around $10.15 on Friday afternoon after closing at $1.79 on Thursday. Nearly 58 million shares shares have been traded, compared with the stock’s 30-day average of 199,000. Small-cap biotech and drug companies tend to have huge positive and negative share-price swings after reporting trial outcomes. The company also reported quarterly earnings on Friday. Its net loss was reduced to $4.8 million from $5.4 million in the year-earlier period, which the company mostly attributed to lower research and development costs.